Single Helix Genomics

Single Helix Genomics, a **biotechnology** startup founded in **2020** and headquartered in the **United States**, is pioneering personalized mRNA synthesis and therapeutics on-demand. The company's slogan, "Personalized mRNA synthesis and therapeutics on-demand," reflects its innovative approach to generating consistent, small-scale cGMP manufacturing of therapeutics-grade mRNA on a timescale of hours. This is made possible through an automated and portable therapeutics-on-demand (TOD) device developed by Single Helix Genomics. The company recently received a **Seed Round** investment on **02 November 2020** from **MBC Biolabs**, marking a significant milestone in its journey. This investment not only validates the potential of Single Helix Genomics' technology and business model but also provides the necessary resources to further develop and commercialize its offerings. With the support of investors like **MBC Biolabs**, Single Helix Genomics is well-positioned to make substantial strides in the field of personalized mRNA synthesis and therapeutics on-demand.